Latest Headlines
Introduction to Definiens Tissue Studio 3 (part III)
Posted on Monday, October 31, 2011
Introduction to Definiens Tissue Studio 3 (part I)
Posted on Friday, October 28, 2011
From the editor: Definiens recently launched a new version of the leading image analysis solution for quantitative digital pathology, Tissue Studio. I will briefly introduce its main features in a loose sequence of posts trying to answer one of the following questions each.
What can Tissue Studio do for you?
Who is Tissue Studio designed for?
Why is Tissue Studio the solution of choice?
Please watch out for forthcoming entries to learn more on new functionality of the new version or have a look at the recordings of the introductory webinar.
Free Webinars: Definiens Introduces New Product Portfolio
Posted on Tuesday, October 25, 2011
Last week, Definiens released a new product portfolio designed to advance biomedical research and tissue-based biomarker development with solutions for image analysis and data mining. It includes updated versions of Definiens Tissue Studio, Definiens Developer XD, as well as a completely novel component, Definiens Image Miner.
Learn more on one of the following occasions:
- Definiens Product launch webinar (October 26 – see the recorded webinar on YouTube)
- Definiens Workshop at Pathology Visions (October 30)
- Definiens Tissue Studio 3 webinar (November 9 – see the recorded webinar on YouTube)
The Definiens team is excited to introduce you to new opportunities in Quantitative Digital Pathology.
Successful Second International Definiens Symposium at the Moffitt Cancer Center
Posted on Friday, October 21, 2011
Around 100 participants joined the Second International Definiens Symposium at the Moffitt Cancer Center in Tampa Florida and made it an inspiring event. The presentations provided a comprehensive overview of image analysis solutions in biopharma and academia – with a focus on tissue-based biomarker development. Keynote lectures by Prof. Dr. Manfred Dietel (Charité, Berlin, Germany) and Dr. Robert Gillies (Moffitt Cancer Center, Tampa, FL) offered insights into present and future of digital pathology. Lunch and coffee breaks and an enjoyable evening event provided ample networking opportunity between participants and the interactive spirit of the meeting was apparent in lively question and answer sessions. Definiens launched a new generation of products at the symposium and profited from immediate feedback in hands-on sessions and discussions with experienced users. New functionalities of Definiens Tissue Studio and Definiens Developer were well received and the new component to the product suite – Definiens Image Miner – attracted particular interest. The organization team is pleased by favorable participant feedback and cordially invites to next year’s symposium that will be held in Europe.
Definiens Releases Pioneering Product Portfolio for Quantitative Digital Pathology and Biomarker Research
Posted on Wednesday, October 12, 2011
Munich, Germany – October 20, 2011 Definiens, the leading Health Image Intelligence™ company, today announced the release of its new Quantitative Digital Pathology portfolio, designed to advance translational research in pathology, specifically in biomarker development. The new portfolio will offer updated versions of Definiens Tissue Studio®, Definiens Developer XD™ as well as the introduction of a novel component, Definiens Image Miner™.
The technology in Definiens’ recently released product suite will provide high accuracy in automatically identifying relevant structures of interest and specific morphology in histology, resulting in a detailed phenotypic fingerprint and biomarker expression profile on a cell-by-cell basis. The large set of descriptors can be correlated against therapy response or patient outcome with the goal of identifying new types of biomarkers of predictive or prognostic value.
